SOFTBANK
7.7.2021 12:32:13 CEST | Business Wire | Press release
SoftBank Group Corp. (“SBG”) today announced that Mark Kornblau will join SBG as Global Head of Communications, effective August 16. Mr. Kornblau joins SBG from the NBCUniversal News Group, where he is currently Executive Vice President of Communications.
Mr. Kornblau will be based in SoftBank's New York office and will report to Masayoshi Son, Representative Director, Corporate Officer, Chairman & CEO of SBG, and Marcelo Claure, Corporate Officer, Executive Vice President & COO of SBG and Chief Executive Officer of SoftBank Group International. In this role, Mr. Kornblau will be responsible for leading SBG's corporate communications strategy, directing the Company's external and internal global communications functions. He will also work with SBG's nearly 300 portfolio companies to foster alignment and value creation across the SoftBank Group ecosystem.
“Mark is a highly regarded and talented communications leader who has been a trusted advisor to CEOs, presidential candidates, government leaders and journalists for more than two decades,” said Mr. Claure. “He will be a valuable partner to our leadership team and the entrepreneurs and companies we invest in.”
Mr. Kornblau said, “SoftBank is at the center of a transformative global moment. It is shaping the future by identifying truly innovative technologies and accelerating the growth of companies that are revolutionizing the way we live and work – for the better. I’m looking forward to supporting that mission.”
At the NBCUniversal News Group, Mr. Kornblau leads communications for the award-winning portfolio of television and digital news brands and positioned the business for success in a rapidly changing media landscape. In this role, Mr. Kornblau partners with business and editorial leaders at the flagship brands of NBC News, MSNBC, TODAY, Nightly News, Meet the Press and their streaming networks and digital platforms. He also led negotiations to secure the network’s 2020 presidential primary debates, which set viewership records.
Prior to his role at NBCUniversal News Group, Mr. Kornblau was Managing Director of Corporate Communications for JPMorgan Chase, where he worked with the executive leadership team on strategic and crisis communications and oversaw media relations in support of the firm's government relations and corporate responsibility efforts.
Previously, Mr. Kornblau served in the Obama Administration as Communications Director and Spokesman for Ambassador Susan Rice at the United States Mission to the United Nations. He has held senior communications roles on two U.S. presidential campaigns, on Capitol Hill and on U.S. House and Senate campaigns.
Mr. Kornblau serves on the Board of Directors for the Careers in Culinary Arts Program, a workforce development non-profit. He received a Bachelor of Arts degree from the University of Wisconsin-Madison.
About SoftBank Group
The SoftBank Group invests in breakthrough technology to improve the quality of life for people around the world. The SoftBank Group is comprised of SoftBank Group Corp. (TOKYO: 9984), an investment holding company that includes stakes in telecommunications, internet services, AI, smart robotics, IoT and clean energy technology providers; the SoftBank Vision Funds, which are investing more than US$100 billion to help extraordinary entrepreneurs transform industries and shape new ones; the $US5 billion SoftBank Latin America Fund, the largest venture fund in that region, and the SB Opportunity Fund, a US$100 million fund dedicated to investing in enterprises founded by entrepreneurs of color in the U.S. To learn more, please visit https://global.softbank .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210707005434/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom